research use only
Cat.No.S2129
|
In vitro |
Water : 36 mg/mL
DMSO
: Insoluble
Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 179.24 | Formula | C6H13NO3S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 13189-98-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C(CO)CSCC(C(=O)O)N | ||
| In vitro |
Fudosteine (FDS), a unique mucolytic antioxidant, shows a stronger scavenging effect of Peroxynitrite than N-acetyl-cysteine on DCDHF oxidation in vitro and in sputum macrophages, and also on Peroxynitrite-induced BSA nitration. This compound (0.1 mM) reduces Peroxynitrite-enhanced interleukin (IL)-1beta-induced IL-8 release and restores corticosteroid sensitivity defected by Peroxynitrite more potently than those induced by H(2)O(2) in A549 airway epithelial cells. It significantly inhibits increases in GRO/CINC-1 at 10-100 mg/kg, and neutrophils and goblet cells at 30 and 100 mg/kg. This chemical inhibits goblet cell hyperplasia by inhibiting GRO/CINC-1 production and/or neutrophil migration. Its treatment reduces the expression levels of p-p38 MAPK and p-ERK in vivo and of p-ERK in vitro. This agent inhibits MUC5AC mucin hypersecretion by reducing MUC5AC gene expression and the effects of this compound are associated with the inhibition of extracellular signal-related kinase and p38 mitogen-activated protein kinase in vivo and extracellular signal-related kinase in vitro. It significantly suppresses blood flow of tracheal microvasculature increased by SO(2) exposure. This substance scavenges superoxide anion generated from rat neutrophils, and enzymatically generated from xanthine oxidase-acetaldehyde reaction.
|
|---|---|
| In vivo |
Fudosteine (500 mg/kg, p.o.) significantly increases the amount of dye excreted into the respiratory tract. This compound increases chloride ion concentration in broncho-alveolar lavage of rats.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.